Dr. David Paul Richman, MD

Dr. Richman practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Richman's NPI, 1497739296, was assigned on December 5, 2005. Dr. Richman graduated from The Johns Hopkins University School of Medicine in 1969. Dr. Richman holds California license G025987.

Dr. Richman's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Richman's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Richman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Richman practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Richman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Richman is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Richman's licenses on file in 4 states: California, New York, Illinois and Florida.

Dmand AI lists cerebrovascular disease, mini-stroke (TIA), muscle disease and neuropathy among the conditions Dr. Richman treats.

CMS data shows 452 Medicare services from Dr. Richman across 5 procedure codes in 2024, for 193 Medicare patients. Medicare paid $24,901 for them. Every service was in an office.

CMS counts 193 Medicare patients who saw Dr. Richman in 2024. The largest group is 75 to 84, with 90 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Richman's median patient age at 65, with 52% women.

In 2024, Dr. Richman wrote 713 Medicare Part D claims for 102 patients. 91% of them were for generic drugs. CMS names the drug for 631 of them, across 6 drugs with 11 or more claims each, at $1,460,086 in total drug cost. In 2023, CMS named 567 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Richman for performance year 2024, reported as part of a group. Dr. Richman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Richman as offering telehealth.

Dmand AI links 71 papers to Dr. Richman, published from 2008 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Myasthenia Gravis, Receptors, Cholinergic and Antibodies, Monoclonal. Dr. Richman has published most often in Ann N Y Acad Sci. Dr. Richman's most frequent co-authors are Mark Angel Agius, MD, Ricardo A. Maselli, MD and Donald Berry Sanders, MD.

Dmand AI links Dr. Richman to 2 clinical trials. Conditions studied include Myasthenia Gravis, Lambert-Eaton Myasthenic Syndrome and Neuromuscular Junction Diseases.

CMS Open Payments shows 2 general payments to Dr. Richman from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $122.

Dmand AI lists 2 awards for Dr. Richman, most recently CMS Stage 1 EHR in 2012.

Dr. Richman graduated from The Johns Hopkins University School of Medicine in 1969.

Dr. Richman is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.